4D Molecular Therapeutics, Inc. (FDMT) total assets

Total assets · fiscal 2025
$566.71M

4D Molecular Therapeutics, Inc. (FDMT) had total assets of $566.71M at the end of fiscal 2025 (December 31, 2025). That is 1.1% higher than the $560.38M of fiscal 2024. Figures as of 18 Nov 2026, 03:08 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total assets, fiscal 2025
$566.71M
Change on fiscal 2024
+1.1%
Growth, 5 years
+14.5% a year
Highest on record
$566.71Mfiscal 2025
Lowest on record
$58.23Mfiscal 2019
Fiscal years on record
72019–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

4D Molecular Therapeutics, Inc. total assets, in more detail

Over the five fiscal years to 2025 total assets grew at a compound 14.5% a year. Across the 7 fiscal years on record (2019–2025), the highest was $566.71M in fiscal 2025 and the lowest $58.23M in fiscal 2019.

History · 7 fiscal years

Total assets by fiscal year

4D Molecular Therapeutics, Inc. total assets, year by year

4D Molecular Therapeutics, Inc. (FDMT) total assets by fiscal year
Fiscal yearTotal assetsChangeYear ended
2025$566.71M 1.1% up
2024$560.38M 64.9% up
2023$339.89M 29.8% up
2022$261.85M 25.9% down
2021$353.49M 22.6% up
2020$288.33M 395.1% up
2019$58.23M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

How to read it

It measures the resources the business has put to work; assets that grow faster than profit mean each new unit of investment is earning less.

More on FDMT

4D Molecular Therapeutics, Inc., figure by figure

4D Molecular Therapeutics, Inc. (FDMT) overview: price, valuation and scorecard

4D Molecular Therapeutics, Inc. total assets: questions and answers

How large are 4D Molecular Therapeutics, Inc.'s total assets?

4D Molecular Therapeutics, Inc. (FDMT) had total assets of $566.71M at the end of fiscal 2025 (December 31, 2025). That is 1.1% higher than the $560.38M of fiscal 2024.

What is the growth rate of 4D Molecular Therapeutics, Inc.'s total assets?

Over the five fiscal years to 2025 total assets grew at a compound 14.5% a year.

What are the highest and lowest total assets figures on record for 4D Molecular Therapeutics, Inc.?

Across the 7 fiscal years on record (2019–2025), the highest was $566.71M in fiscal 2025 and the lowest $58.23M in fiscal 2019.

How is 4D Molecular Therapeutics, Inc.'s total assets calculated?

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “4D Molecular Therapeutics, Inc. (FDMT) total assets”, data as of 18 November 2026. https://funkfolio.com/stock/FDMT/total-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.